Blue Owl Capital Holdings
Blue Owl Capital Holdings reported 71 stocks worth $658M in its 13F filing for Q2 2026, filed Aug 11, 2026. Its largest holdings are SPCX (36.3%), AKTS (15.0%) and CGEM (4.3%). Compared with Q1 2026, the fund opened new positions in SPCX, COF and FISN, added to LRMR, DELL and HLLY, trimmed AKTS, CGEM and MPLT and sold out of CMPS, CVEO and OVID.
Holdings
| # | Stock | Value | Weight | Shares | Change | Shares, 8 qtrs | Held |
|---|---|---|---|---|---|---|---|
| 1 | ![]() SPCX Space Exploration Techn Corp Class A Com Stk | $239M | 36.3% | 1.4M | New position | 1 of 8 | |
| 2 | ![]() AKTS Aktis Oncology Inc | $99M | 15.0% | 3.1M | −91K (−3%) | 2 of 8 | |
| 3 | ![]() CGEM Cullinan Therapeutics Inc | $28M | 4.3% | 1.5M | −370K (−19%) | 8 of 8 | |
| 4 | ![]() LRMR Larimar Therapeutics Inc | $27.9M | 4.3% | 9.2M | +2M (+29%) | 8 of 8 | |
| 5 | ![]() NCDL Nuveen Churchill Direct Lend Com SH | $26.6M | 4.0% | 2.1M | No change | 8 of 8 | |
| 6 | ![]() MPLT Maplight Therapeutics Inc | $26.2M | 4.0% | 730K | −276K (−27%) | 3 of 8 | |
| 7 | ![]() COF Capital One Finl Corp | $24M | 3.6% | 120K | New position | 1 of 8 | |
| 8 | ![]() OBDC Blue Owl Capital Corporation | $22.2M | 3.4% | 2M | No change | 8 of 8 | |
| 9 | ![]() FISN Deep Fission Inc | $14.7M | 2.2% | 1.3M | New position | 1 of 8 | |
| 10 | ![]() DELL Dell Technologies Inc | $14.2M | 2.2% | 33K | +19K (+137%) | 5 of 8 |
Positions at Jun 30, 2026, as reported. Change is against the fund's Q1 2026 filing; weight is the share of the fund's reported stocks.
Sold out
held in Q1 2026, gone in Q2 2026| Stock | Value last quarter | Shares sold |
|---|---|---|
ENGENE HOLDINGS INC | $30.1M | 4.4M |
![]() CMPS Compass Pathways PLC | $5.1M | 1.8M |
![]() CVEO Civeo Corp | $4.8M | 180K |
KALVISTA PHARMACEUTICALS INC | $4.3M | 215K |
![]() OVID Ovid Therapeutics Inc | $4.2M | 1.9M |
🔒 Free account: see all 22.
Options
valued at the underlying sharesReported value
last 8 quartersThe value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.
Filings for Q2 2026
straight from the SEC| Filed | Form | Quarter | |
|---|---|---|---|
| Aug 11, 2026 | 13F-HR | Q2 2026 | SEC filing ↗ |
Other superinvestors
All hedge fund holdings →Blue Owl Capital Holdings 13F FAQ
What does Blue Owl Capital Holdings own?
Blue Owl Capital Holdings reported 71 stocks worth $658M in its 13F filing for Q2 2026, filed Aug 11, 2026. Its largest holdings are SPCX (36.3%), AKTS (15.0%) and CGEM (4.3%). The table above lists every position in the filing (the top 10 without an account).
What did Blue Owl Capital Holdings buy and sell in Q2 2026?
Compared with Q1 2026: 18 new positions, 11 added to, 13 trimmed and 22 sold out. New positions include SPCX, COF and FISN. It sold all of CMPS, CVEO and OVID.
When will Blue Owl Capital Holdings file its next 13F?
Holdings as of Sep 30, 2026 are due by Nov 16, 2026. The filing appears on this page within minutes of reaching the SEC.
How much is Blue Owl Capital Holdings's portfolio worth?
The Q2 2026 filing reports $658M in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.















